BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 9059978)

  • 21. Human metabolism of phytanic acid and pristanic acid.
    Verhoeven NM; Jakobs C
    Prog Lipid Res; 2001 Nov; 40(6):453-66. PubMed ID: 11591435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemistry of mammalian peroxisomes revisited.
    Wanders RJ; Waterham HR
    Annu Rev Biochem; 2006; 75():295-332. PubMed ID: 16756494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peroxisomes and peroxisomal disorders: the main facts.
    Fidaleo M
    Exp Toxicol Pathol; 2010 Nov; 62(6):615-25. PubMed ID: 19740638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic aspects of peroxisomal beta-oxidation.
    Osmundsen H; Bremer J; Pedersen JI
    Biochim Biophys Acta; 1991 Sep; 1085(2):141-58. PubMed ID: 1892883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Peroxisomal beta-oxidation].
    Mannaerts GP; Van Veldhoven PP
    Verh K Acad Geneeskd Belg; 1993; 55(1):45-78. PubMed ID: 8480447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peroxisome mosaicism in the livers of peroxisomal deficiency patients.
    Espeel M; Mandel H; Poggi F; Smeitink JA; Wanders RJ; Kerckaert I; Schutgens RB; Saudubray JM; Poll-The BT; Roels F
    Hepatology; 1995 Aug; 22(2):497-504. PubMed ID: 7635418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The chemical biology of branched-chain lipid metabolism.
    Mukherji M; Schofield CJ; Wierzbicki AS; Jansen GA; Wanders RJ; Lloyd MD
    Prog Lipid Res; 2003 Sep; 42(5):359-76. PubMed ID: 12814641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenotypic variability (heterogeneity) of peroxisomal disorders.
    Mandel H; Korman SH
    Adv Exp Med Biol; 2003; 544():9-30. PubMed ID: 14713208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormality in catalase import into peroxisomes leads to severe neurological disorder.
    Sheikh FG; Pahan K; Khan M; Barbosa E; Singh I
    Proc Natl Acad Sci U S A; 1998 Mar; 95(6):2961-6. PubMed ID: 9501198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid metabolism in peroxisomes in relation to human disease.
    Wanders RJ; Tager JM
    Mol Aspects Med; 1998 Apr; 19(2):69-154. PubMed ID: 9827430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peroxisomes, peroxisomal diseases, and the hepatotoxicity induced by peroxisomal metabolites.
    Wanders RJ; Ferdinandusse S
    Curr Drug Metab; 2012 Dec; 13(10):1401-11. PubMed ID: 22978395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Peroxisomal disorders in neurology].
    Orii T; Hashimoto T
    No To Hattatsu; 1992 Mar; 24(2):174-5. PubMed ID: 1567653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantification of Very-Long-Chain and Branched-Chain Fatty Acids in Plasma by Liquid Chromatography-Tandem Mass Spectrometry.
    De Biase I; Pasquali M
    Methods Mol Biol; 2022; 2546():509-521. PubMed ID: 36127618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measurement of peroxisomal fatty acid beta-oxidation in cultured human skin fibroblasts.
    Wanders RJ; Denis S; Ruiter JP; Schutgens RB; van Roermund CW; Jacobs BS
    J Inherit Metab Dis; 1995; 18 Suppl 1():113-24. PubMed ID: 9053546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peroxisomes, lipid metabolism, and peroxisomal disorders.
    Wanders RJ
    Mol Genet Metab; 2004; 83(1-2):16-27. PubMed ID: 15464416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peroxisomal fatty acid alpha- and beta-oxidation in humans: enzymology, peroxisomal metabolite transporters and peroxisomal diseases.
    Wanders RJ; Vreken P; Ferdinandusse S; Jansen GA; Waterham HR; van Roermund CW; Van Grunsven EG
    Biochem Soc Trans; 2001 May; 29(Pt 2):250-67. PubMed ID: 11356164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperpipecolic acidaemia: a diagnostic tool for peroxisomal disorders.
    Peduto A; Baumgartner MR; Verhoeven NM; Rabier D; Spada M; Nassogne MC; Poll-The BT; Bonetti G; Jakobs C; Saudubray JM
    Mol Genet Metab; 2004 Jul; 82(3):224-30. PubMed ID: 15234336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dyggve-Melchior-Clausen syndrome with increased pipecolic acid in plasma and urine.
    Roesel RA; Carroll JE; Rizzo WB; van der Zalm T; Hahn DA
    J Inherit Metab Dis; 1991; 14(6):876-80. PubMed ID: 1779646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peroxisomal dysfunction in neurodegenerative diseases.
    Jo DS; Cho DH
    Arch Pharm Res; 2019 May; 42(5):393-406. PubMed ID: 30739266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel functions of acyl-CoA thioesterases and acyltransferases as auxiliary enzymes in peroxisomal lipid metabolism.
    Hunt MC; Alexson SE
    Prog Lipid Res; 2008 Nov; 47(6):405-21. PubMed ID: 18538142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.